Skip to menu Skip to content Skip to footer

Deciphering the role of lactylation, a novel protein post-translational modification, in ALS (2026-2027)

Abstract

This project seeks to uncover how lactylation, a recently identified post-translational modification regulated by lactate metabolism, contributes to ALS pathology. Our preliminary data reveal that lactylation occurs on key ALS-associated proteins, including TDP-43 and SOD1. We will define lactylation signatures in ALS, determine how this modification influences TDP-43 and SOD1 mislocalisation and aggregation, and assess whether modulating lactylation can confer neuroprotection. These studies will provide new mechanistic insights into ALS and establish whether lactylation represents a viable therapeutic target.

Experts

Ms Thais Sobanski

Postdoctoral Research Fellow
Australian Institute for Bioengineering and Nanotechnology
Thais Sobanski
Thais Sobanski

Associate Professor Frederik Steyn

Centre Director of Centre for Motor Neuron Disease Research
Centre for Motor Neuron Disease Research
Faculty of Health, Medicine and Behavioural Sciences
Associate Professor
School of Biomedical Sciences
Faculty of Health, Medicine and Behavioural Sciences
Frederik Steyn
Frederik Steyn